amikacin has been researched along with Febrile Neutropenia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Da, VR; Gc, FT; Pa, CC; Se, CF | 1 |
| Abu Taha, A; Aiesh, BM; Amer, R; Hamed Allah, M; Joudeh, N; Odeh, RY; Sabateen, A; Salameh, H; Sawafta, E; Zyoud, SH | 1 |
| Bouscary, D; Canouï, E; Charlier, C; Contejean, A; Fantin, B; Garcia-Vidal, C; Kernéis, S; Maillard, A; Parize, P | 1 |
| Charoenkwan, P; Choeyprasert, W; Fanhchaksai, K; Kamonrattana, R; Natesirinilkul, R; Sathitsamitphong, L | 1 |
| Juan-Shum, L; López-Aguilar, JE; Miranda-Novales, MG; Pacheco-Rosas, DO; Peregrino-Bejarano, L | 1 |
| Bello, L; Caneiro, A; Gai, R; Galeano, S; Miller, A; Mosquera, R; Muxi, P; Oliver, AC; Pierri, S; Riva, E | 1 |
| Chen, Y; Du, Z; Liu, Y; Wang, Y; Yang, Z | 1 |
| Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
| Cho, SY; Chung, DR; Kang, CI; Kim, SH; Ko, JH; Lee, NY; Peck, KR; Song, JH | 1 |
| Emiroğlu, M; Köksal, Y; Köse, D | 1 |
| Ayçiçek, A; Koç, A; Özdemir, ZC | 1 |
2 review(s) available for amikacin and Febrile Neutropenia
| Article | Year |
|---|---|
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Febrile Neutropenia; Hematologic Neoplasms; Humans; Vancomycin | 2023 |
Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Febrile Neutropenia; Humans; Meropenem; Neoplasms | 2021 |
2 trial(s) available for amikacin and Febrile Neutropenia
| Article | Year |
|---|---|
A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
Topics: Administration, Intravenous; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Male; Neoplasms; Piperacillin; Prospective Studies; Retrospective Studies; Tazobactam; Treatment Outcome | 2019 |
Piperacillin/tazobactam plus amikacin vs. piperacilin/tazobactam: treatment for children with febrile neutropenia
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infant; Intention to Treat Analysis; Logistic Models; Male; Neoplasms; Piperacillin, Tazobactam Drug Combination | 2019 |
7 other study(ies) available for amikacin and Febrile Neutropenia
| Article | Year |
|---|---|
Aminoglycosides' dosage in hematological malignancies and febrile neutropenia: extended interval or conventional dosage?
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Febrile Neutropenia; Hematologic Neoplasms; Humans | 2023 |
Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Developing Countries; Febrile Neutropenia; Female; Fever; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2023 |
Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
Topics: Adolescent; Adult; Aged; Amikacin; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftazidime; Ciprofloxacin; Febrile Neutropenia; Female; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Incidence; Levofloxacin; Male; Meropenem; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Autologous; Uruguay; Young Adult | 2020 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Febrile Neutropenia; Humans; Piperacillin, Tazobactam Drug Combination | 2019 |
High-risk febrile neutropenia and its management in children with solid tumors and lymphoma.
Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Child; Febrile Neutropenia; Female; Humans; Imipenem; Lymphoma; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Precursors | 2015 |
Microorganisms isolated from cultures and infection focus and antibiotic treatments in febrile neutropenic children from Şanlıurfa, Turkey.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Humans; Infant; Leukemia; Male; Retrospective Studies; Treatment Outcome; Turkey | 2016 |